1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lyme Disease Diagnostic Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Lyme Disease Diagnostic Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Lyme Disease Diagnostic Devices by Country/Region, 2018, 2022 & 2029
2.2 Lyme Disease Diagnostic Devices Segment by Type
2.2.1 Serological Test
2.2.2 Urine Antigen Tests
2.2.3 Lymphocytic Transformation Test
2.2.4 Immunofluorescent Staining
2.2.5 Nucleic Acid Test
2.3 Lyme Disease Diagnostic Devices Sales by Type
2.3.1 Global Lyme Disease Diagnostic Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Lyme Disease Diagnostic Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Lyme Disease Diagnostic Devices Sale Price by Type (2018-2023)
2.4 Lyme Disease Diagnostic Devices Segment by Application
2.4.1 Hospitals
2.4.2 Public/Private Laboratories
2.4.3 Physician’s Office
2.5 Lyme Disease Diagnostic Devices Sales by Application
2.5.1 Global Lyme Disease Diagnostic Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Lyme Disease Diagnostic Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Lyme Disease Diagnostic Devices Sale Price by Application (2018-2023)
3 Global Lyme Disease Diagnostic Devices by Company
3.1 Global Lyme Disease Diagnostic Devices Breakdown Data by Company
3.1.1 Global Lyme Disease Diagnostic Devices Annual Sales by Company (2018-2023)
3.1.2 Global Lyme Disease Diagnostic Devices Sales Market Share by Company (2018-2023)
3.2 Global Lyme Disease Diagnostic Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Lyme Disease Diagnostic Devices Revenue by Company (2018-2023)
3.2.2 Global Lyme Disease Diagnostic Devices Revenue Market Share by Company (2018-2023)
3.3 Global Lyme Disease Diagnostic Devices Sale Price by Company
3.4 Key Manufacturers Lyme Disease Diagnostic Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lyme Disease Diagnostic Devices Product Location Distribution
3.4.2 Players Lyme Disease Diagnostic Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lyme Disease Diagnostic Devices by Geographic Region
4.1 World Historic Lyme Disease Diagnostic Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Lyme Disease Diagnostic Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Lyme Disease Diagnostic Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Lyme Disease Diagnostic Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Lyme Disease Diagnostic Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Lyme Disease Diagnostic Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Lyme Disease Diagnostic Devices Sales Growth
4.4 APAC Lyme Disease Diagnostic Devices Sales Growth
4.5 Europe Lyme Disease Diagnostic Devices Sales Growth
4.6 Middle East & Africa Lyme Disease Diagnostic Devices Sales Growth
5 Americas
5.1 Americas Lyme Disease Diagnostic Devices Sales by Country
5.1.1 Americas Lyme Disease Diagnostic Devices Sales by Country (2018-2023)
5.1.2 Americas Lyme Disease Diagnostic Devices Revenue by Country (2018-2023)
5.2 Americas Lyme Disease Diagnostic Devices Sales by Type
5.3 Americas Lyme Disease Diagnostic Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lyme Disease Diagnostic Devices Sales by Region
6.1.1 APAC Lyme Disease Diagnostic Devices Sales by Region (2018-2023)
6.1.2 APAC Lyme Disease Diagnostic Devices Revenue by Region (2018-2023)
6.2 APAC Lyme Disease Diagnostic Devices Sales by Type
6.3 APAC Lyme Disease Diagnostic Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lyme Disease Diagnostic Devices by Country
7.1.1 Europe Lyme Disease Diagnostic Devices Sales by Country (2018-2023)
7.1.2 Europe Lyme Disease Diagnostic Devices Revenue by Country (2018-2023)
7.2 Europe Lyme Disease Diagnostic Devices Sales by Type
7.3 Europe Lyme Disease Diagnostic Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lyme Disease Diagnostic Devices by Country
8.1.1 Middle East & Africa Lyme Disease Diagnostic Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Lyme Disease Diagnostic Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Lyme Disease Diagnostic Devices Sales by Type
8.3 Middle East & Africa Lyme Disease Diagnostic Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lyme Disease Diagnostic Devices
10.3 Manufacturing Process Analysis of Lyme Disease Diagnostic Devices
10.4 Industry Chain Structure of Lyme Disease Diagnostic Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lyme Disease Diagnostic Devices Distributors
11.3 Lyme Disease Diagnostic Devices Customer
12 World Forecast Review for Lyme Disease Diagnostic Devices by Geographic Region
12.1 Global Lyme Disease Diagnostic Devices Market Size Forecast by Region
12.1.1 Global Lyme Disease Diagnostic Devices Forecast by Region (2024-2029)
12.1.2 Global Lyme Disease Diagnostic Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lyme Disease Diagnostic Devices Forecast by Type
12.7 Global Lyme Disease Diagnostic Devices Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.1.3 Abbott Laboratories Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 T2 Biosystems, Inc.
13.2.1 T2 Biosystems, Inc. Company Information
13.2.2 T2 Biosystems, Inc. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.2.3 T2 Biosystems, Inc. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 T2 Biosystems, Inc. Main Business Overview
13.2.5 T2 Biosystems, Inc. Latest Developments
13.3 Bio-Rad Laboratories
13.3.1 Bio-Rad Laboratories Company Information
13.3.2 Bio-Rad Laboratories Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.3.3 Bio-Rad Laboratories Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bio-Rad Laboratories Main Business Overview
13.3.5 Bio-Rad Laboratories Latest Developments
13.4 Alere Inc.
13.4.1 Alere Inc. Company Information
13.4.2 Alere Inc. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.4.3 Alere Inc. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Alere Inc. Main Business Overview
13.4.5 Alere Inc. Latest Developments
13.5 Roche Diagnostics
13.5.1 Roche Diagnostics Company Information
13.5.2 Roche Diagnostics Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.5.3 Roche Diagnostics Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Roche Diagnostics Main Business Overview
13.5.5 Roche Diagnostics Latest Developments
13.6 Covance Inc.
13.6.1 Covance Inc. Company Information
13.6.2 Covance Inc. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.6.3 Covance Inc. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Covance Inc. Main Business Overview
13.6.5 Covance Inc. Latest Developments
13.7 Immunetics, Inc.
13.7.1 Immunetics, Inc. Company Information
13.7.2 Immunetics, Inc. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.7.3 Immunetics, Inc. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Immunetics, Inc. Main Business Overview
13.7.5 Immunetics, Inc. Latest Developments
13.8 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd)
13.8.1 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Company Information
13.8.2 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.8.3 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Main Business Overview
13.8.5 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Latest Developments
13.9 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.)
13.9.1 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Company Information
13.9.2 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.9.3 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Main Business Overview
13.9.5 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Latest Developments
13.10 Thermo Fisher Scientific(Affymetrix)
13.10.1 Thermo Fisher Scientific(Affymetrix) Company Information
13.10.2 Thermo Fisher Scientific(Affymetrix) Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.10.3 Thermo Fisher Scientific(Affymetrix) Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Thermo Fisher Scientific(Affymetrix) Main Business Overview
13.10.5 Thermo Fisher Scientific(Affymetrix) Latest Developments
13.11 Siemens AG
13.11.1 Siemens AG Company Information
13.11.2 Siemens AG Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.11.3 Siemens AG Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Siemens AG Main Business Overview
13.11.5 Siemens AG Latest Developments
13.12 Baxter International Inc.
13.12.1 Baxter International Inc. Company Information
13.12.2 Baxter International Inc. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.12.3 Baxter International Inc. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Baxter International Inc. Main Business Overview
13.12.5 Baxter International Inc. Latest Developments
13.13 Fresenius Medical Care AG & Co.
13.13.1 Fresenius Medical Care AG & Co. Company Information
13.13.2 Fresenius Medical Care AG & Co. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.13.3 Fresenius Medical Care AG & Co. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Fresenius Medical Care AG & Co. Main Business Overview
13.13.5 Fresenius Medical Care AG & Co. Latest Developments
14 Research Findings and Conclusion
| ※参考情報 ライム病診断装置は、ライム病の早期発見と診断を目的とした医療機器です。ライム病は、主にマダニによって媒介される感染症で、病原体はスピロヘータと呼ばれる細菌であるボレリア属の一種です。この病気は特に北米やヨーロッパで多く見られ、感染により発熱、頭痛、疲労感、そして特に特徴的な皮膚病変である「バルボンラッシュ」と呼ばれる紅斑が現れます。早期の診断が行われない場合、関節炎や心筋炎、神経症状を引き起こすこともあり、そのため、的確な診断を行うための装置が必要です。 ライム病診断装置の主な特徴は、迅速性と精度です。現代の医療技術の進展により、従来の血清学的検査に加え、分子生物学的手法を利用した検査方法が開発されています。これにより、患者の血液や組織からボレリアのDNAを直接検出することが可能になり、より早期かつ正確な診断が期待されています。また、検査装置自体も、小型化や簡便化が進んでおり、医療現場での取り扱いが容易となっています。 ライム病診断装置には主に2つの種類があります。1つは血清学的検査装置で、これは血液中の抗体を測定します。ライム病の初期には、抗体が検出されるまでに時間がかかるため、感染の可能性がある場合には、体液の他のマーカーを組み合わせて診断を行うことが一般的です。もう1つは分子診断装置で、こちらはポリメラーゼ連鎖反応（PCR）を使用してボレリアのDNAを増幅し、迅速に検出することができます。PCR検査は、感染初期段階でも高い感度を持ち、早期の診断が可能になりますが、専門的な技術と機器が必要であるため、医療機関の設備に依存します。 ライム病診断装置の用途は多岐にわたります。主な使用者は、病院やクリニックなどの医療機関で、ライム病の疑いがある患者に対して迅速かつ正確な診断を行うことです。また、研究機関や公共衛生関連機関でも、感染症の流行状況を把握するための疫学調査や、製品の開発に使用されています。加えて、ライム病が流行している地域では、家庭や野外活動を行う際の予防手段として、セルフチェックキットが販売されていることもあります。これにより、個々の利用者が自己判断でライム病のリスクを把握する助けとなっています。 関連する技術としては、遺伝子診断技術が重要です。PCR以外にも、次世代シークエンシング（NGS）技術が進展しており、ボレリア属の全ゲノム解析が可能になっています。これにより、感染源の特定や、異なるボレリア株の比較研究が注目されています。また、マダニのモニタリング技術も関連性が高いです。具体的には、マダニの捕獲とその中に存在するボレリアDNAの検出が、ライム病のリスク評価に役立ちます。これにより、特定地域での発生リスクを推定し、適切な対策を講じることが可能となります。 近年では、AI技術の活用も注目されています。診断プロセスにAIを取り入れることで、過去の診断データや感染症の流行パターンを学習し、高精度な予測が可能になります。この技術は、臨床現場だけでなく、研究機関での疫学研究においても期待されています。 また、ライム病の診断に関する公衆衛生の取り組みも重要です。過去数十年にわたり、ライム病の患者数は増加しており、そのため、早期発見と治療の重要性が強調されています。地域保健機関では、予防教育や感染症の発生に関する情報提供を行い、コミュニティ全体での取り組みが進められています。 ライム病診断装置は、ライム病の早期発見を通じて患者の健康を守る重要な役割を担っています。医療技術の進展とともに、その精度や使いやすさは向上し、今後さらなる革新が期待されます。これらの診断装置を利用することで、ライム病による脅威を軽減し、感染症の流行を抑えるための重要な一歩となるでしょう。 |
